Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Vaccitech names Nadège Pelletier as chief scientific officer

By Brian Buntz | January 30, 2023

VaccitechThe clinical-stage biopharma Vaccitech (Nasdaq:VACC) has appointed Nadège Pelletier as its new chief scientific officer. She will lead scientific teams in drug discovery and platform development at the company and will oversee its technical strategy.

Vaccitech is a UK-based biotech that develops vaccines and immunotherapies.

“It’s an exciting time to be joining Vaccitech,” Pelletier said in a news release.

Pelletier comes to Vaccitech with more than 15 years of experience in the pharma industry and academia.

Specializing in immunology and infectious diseases, she most recently worked as the senior principal scientist, autoimmunity, transplantation and inflammation at the Novartis Institutes for BioMedical Research (NIBR). At Novartis, Pelletier served as project leader in autoimmunity, inflammation and infectious diseases. She was accountable for building solid preclinical packages and developing biomarker strategies and translational plans.

Nadège Pelletier

Nadège Pelletier

Before that, Pelletier worked as a principal scientist and investigator at Roche. In that role, she worked on preclinical and clinical projects to promote immune balance in autoimmunity and chronic infectious diseases. She also worked on advanced immune modulation strategies for chronic hepatitis B and respiratory infections.

She holds a Ph.D. in immunology from the Université Claude Bernard Lyon 1.

Vaccitech’s former chief scientific officer, Tom Evans, is retiring. He will continue working for the company as a scientific consultant.

Vaccitech was founded in 2016.

The company partnered with the University of Oxford to develop ChAdOx1 nCoV-19, a COVID-19 vaccine that AstraZeneca (LON:AZN) eventually helped commercialize. ChAdOx1 eventually won emergency use authorization in several countries and was administered to millions of people worldwide.

Vaccitech is also developing a range of therapeutic and prophylactic therapies.

In the former category is VTP-300, a hepatitis B virus therapeutic in a Phase 2 study. The company also has a human papillomavirus therapeutic known as VTP-200 and a prostate cancer known as VTP-800/850 in Phase 2 studies.

Vaccitech also has MERS and zoster vaccines in clinical development.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE